Search Results - "Boczkowski, David"
-
1
Vaccination against the forkhead family transcription factor foxp3 enhances tumor immunity
Published in Cancer research (Chicago, Ill.) (2007)“…Depletion of CD4+CD25+ regulatory T cells (Treg) by treatment with alphaCD25 antibody synergizes with vaccination protocols to engender protective immunity in…”
Get full text
Journal Article -
2
Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms
Published in Frontiers in immunology (28-07-2023)“…Monocytes and monocyte-derived tumor infiltrating cells have been implicated in the immunosuppression and immune evasion associated with pancreatic…”
Get full text
Journal Article -
3
Spatial biology analysis reveals B cell follicles in secondary lymphoid structures may regulate anti-tumor responses at initial melanoma diagnosis
Published in Frontiers in immunology (15-08-2022)“…B cells are key regulators of immune responses in melanoma. We aimed to explore differences in the histologic location and activation status of B cell…”
Get full text
Journal Article -
4
Tumor immunotherapy targeting fibroblast activation protein, a product expressed in tumor-associated fibroblasts
Published in Cancer research (Chicago, Ill.) (01-12-2005)“…Murine studies have shown that immunologic targeting of the tumor vasculature, a key element of the tumor stroma, can lead to protective immunity in the…”
Get full text
Journal Article -
5
Multimodality analysis confers a prognostic benefit of a T-cell infiltrated tumor microenvironment and peripheral immune status in patients with melanoma
Published in Journal for immunotherapy of cancer (01-09-2022)“…BackgroundWe previously reported results from a phase 1 study testing intratumoral recombinant poliovirus, lerapolturev, in 12 melanoma patients. All 12…”
Get full text
Journal Article -
6
Synergy between tumor immunotherapy and antiangiogenic therapy
Published in Blood (01-08-2003)“…This study tested the hypothesis that combination of antiangiogenic therapy and tumor immunotherapy of cancer is synergistic. To inhibit angiogenesis, mice…”
Get full text
Journal Article -
7
Immunologic targeting of FOXP3 in inflammatory breast cancer cells
Published in PloS one (14-01-2013)“…The forkhead transcription factor FOXP3 is necessary for induction of regulatory T lymphocytes (Tregs) and their immunosuppressive function. We have previously…”
Get full text
Journal Article -
8
Induction of CD4+ and CD8+ T-Cell Responses to the Human Stromal Antigen, Fibroblast Activation Protein: Implication for Cancer Immunotherapy
Published in Clinical cancer research (01-08-2005)“…Purpose: The propensity of tumor cells to escape immune elimination could limit, if not defeat, the long-term benefits of effective immunotherapeutic…”
Get full text
Journal Article -
9
Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization
Published in Immunity (Cambridge, Mass.) (16-01-2018)“…Despite recent advances, many cancers remain refractory to available immunotherapeutic strategies. Emerging evidence indicates that the tolerization of local…”
Get full text
Journal Article -
10
Cancer immunotherapy with recombinant poliovirus induces IFN-dominant activation of dendritic cells and tumor antigen-specific CTLs
Published in Science translational medicine (20-09-2017)“…Tumors thrive in an immunosuppressive microenvironment that impedes antitumor innate and adaptive immune responses. Thus, approaches that can overcome…”
Get more information
Journal Article -
11
The Quest for mRNA Vaccines
Published in Nucleic acid therapeutics (01-12-2022)“…The success of mRNA vaccines against COVID-19 is nothing short of a medical revolution. Given its chemical lability the use of mRNA as a therapeutic has been…”
Get more information
Journal Article -
12
Cancer mRNA vaccines: clinical advances and future opportunities
Published in Nature reviews. Clinical oncology (01-07-2024)“…mRNA vaccines have been revolutionary in terms of their rapid development and prevention of SARS-CoV-2 infections during the COVID-19 pandemic, and this…”
Get full text
Journal Article -
13
Controlling cancer-induced inflammation with a nucleic acid scavenger prevents lung metastasis in murine models of breast cancer
Published in Molecular therapy (05-05-2021)“…Tumor cells release nucleic acid-containing proinflammatory complexes, termed nucleic acid-containing damage-associated molecular patterns (NA DAMPs),…”
Get full text
Journal Article -
14
Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating Aptamer
Published in Chemistry & biology (21-07-2008)“…We show that a molecular scaffold can be utilized to convert a receptor binding aptamer into a receptor agonist. Many receptors (including tumor necrosis…”
Get full text
Journal Article -
15
Targeting DAMP-induced inflammation to prevent breast cancer metastasis and improve anti-tumor immunity
Published in The Journal of immunology (1950) (01-05-2019)“…Abstract Biomarkers associated with systemic inflammation correlate with poor prognosis in cancer patients. Circulating cell-free DNA (cfDNA) is released…”
Get full text
Journal Article -
16
Oncolytic poliovirus immunotherapy for breast cancer
Published in The Journal of immunology (1950) (01-05-2020)“…Abstract Oncolytic poliovirus PVSRIPO is a recombinant, non-pathogenic polio:rhinovirus chimera that enters cells via the poliovirus receptor CD155. CD155…”
Get full text
Journal Article -
17
RNA as performance-enhancers for dendritic cells
Published in Expert opinion on biological therapy (01-04-2010)“…Although studies have demonstrated that antigen-loaded dendritic cells (DC) elicit antigen-specific immune responses, the clinical benefit from DC-based cancer…”
Get more information
Journal Article -
18
Abstract P3-01-03: Modulating inflammation with nucleic acid scavengers to prevent breast cancer metastasis
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Abstract Rationale: Chronic inflammation is a hallmark of cancer. Inflammation, whether it is an underlying baseline condition or induced/exacerbated due to…”
Get full text
Journal Article -
19
Targeting inflammation to prevent breast cancer metastasis
Published in The Journal of immunology (1950) (01-05-2018)“…Abstract Biomarkers associated with systemic inflammation correlate with poor prognosis in cancer patients. Circulating cell-free DNA (cfDNA) is released…”
Get full text
Journal Article -
20
Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells
Published in Clinical cancer research (15-05-2014)“…Despite aggressive conventional therapy, glioblastoma (GBM) remains uniformly lethal. Immunotherapy, in which the immune system is harnessed to specifically…”
Get full text
Journal Article